Solicitation Amendment - HT942627QE0030002.pdf
PDF 3 MB Posted
- Solicitation number
- HT942627QE003
- Issued by
-
Defense Health Agency
About this file
This is a Request for Quotation (RFQ) issued by the Defense Health Agency for consumable supplies supporting Terumo Trima Accel blood collection systems. The solicitation number is HT942627QE0030002, issued on 16 October 2026, with a quote due date of 6 November 2026 at 12:00 PM EDT.
The requirement is for consumable supplies specific to the Terumo Trima Accel blood collection system, which are FDA-approved products with no generic substitutes available in the marketplace. Required items include Teruflex 500ml collection bags, Trima Platelet Kits, Isoplasate Solution (PAS-F), TSCD Wafers, ACD-A Solution, and 150 mL couplers. This is a Service-Disabled Veteran-Owned Small Business set-aside with 100 percent set-aside requirement. The procurement will result in a Blanket Purchase Agreement (BPA) issued on DD Form 1155 with a continuous 60-month ordering period and a maximum ceiling of $350,000.00 across all Call Orders and GPC orders. Individual Call Orders shall not exceed $50,000.00, while GPC Ordering Officers are limited to purchases of $15,000.00 maximum. All Call Orders will be awarded as Firm Fixed Price acquisitions. Delivery is to the U.S. Army Institute of Surgical Research, Fort Sam Houston, Texas. Quotations must consist of two separate volumes: Volume I (non-price, including executed solicitation documents and technical capability not exceeding 20 pages) and Volume II (price quote using the Government-provided pricing sheet and published price list with discounts). The evaluation will be on a Lowest Price Technically Acceptable basis, with award anticipated to the responsible Offeror whose quote conforms to the solicitation and provides best value to the Government.
View the file
Other files
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
(1) The agency's evaluation of the significant weak or deficient factors in the debriefed Offeror's offer.
HT942627QE0030002
(2) The overall evaluated cost or price and technical rating of the successful Offeror and the debriefed Offeror and past performance information on the debriefed Offeror.
(3) The overall ranking of all Offerors when any ranking was developed by the agency during source selection.
(4) A summary of the rationale for award.
(5) For acquisitions of commercial products, the make and model of the product to be delivered by the successful Offeror.
(6) Reasonable responses to relevant questions posed by the debriefed Offeror as to whether the agency followed source-selection procedures set forth in the solicitation, applicable regulations, and other applicable authorities.
**52.212-1 Addendum for instructions to offerors**
1. Questions shall be submitted via email to the primary point-of-contact, Mr. Eric Zampelli, eric.m.zampelli.civ@health.mil; and Mr. Jeremy McMurry, Jeremy.l.mcmurry.civ@health.mil; no later than 22 October 2026 at 12:00 PM Eastern Daylight Time (Eon. Questions received after this date and time will not be accepted. Quotes are due no later than 6 November 2026 at 12:00 PM EDT.
No telephone calls will be accepted. No questions shall be addressed after the due date. An Amendment to this solicitation will be submitted to the offeror providing the answers to all questions received via email.
2. INSTRUCTIONS FOR THE PREPARATION AND SUBMISSION OF QUOTATIONS
Failure to submit all documents concurrently or in accordance with these instructions may render a quote unacceptable. The Government will not consider pages submitted in excess of the stated page limitations. Quotes shall provide a minimum offer acceptance period of ninety (90) days (including an agreement to hold the prices in offer firm) after the required date for receipt of quotes.
2.1. QUOTATION EVALUATION
To aid in evaluation, quotes shall be practical, specific, and complete as well as being indexed (cross-indexed, as appropriate) and logically assembled. The quote shall be in a clear and concise form. All pages of each Volume shall be numbered and dated and include the solicitation number.
2.2. PRICE INFORMATION. Price information shall be included in the price Volume only. The proposed price shall not be discussed or exhibited in any other Volume of the
Offeror's quote.
The overall quote shall consist of two (2) separate Volumes, individually titled. All copies of each Volume shall be appropriately titled.
Quote Volumes Volume Title
Volume I - Non-Price
Executed Solicitation Documents (Representations and Certifications)
Executive Summary, Technical Capability
Volume II - Price
Price Quote
Published Price List (with discounts %) (web address or document)
3. PAGE LIMITATIONS
3.1. There are page limitations associated with portions of Volume I. If the Offeror's quote exceeds the defined page limitations, the pages exceeding the limit will be removed and will not be evaluated. Quotes shall be single-sided, typed in 12-point, Times New Roman font using 1" margins on the top, bottom, and sides. Graphics, tables, and matrices are exempt from the 12-point font requirement; however, any materials not legible to the evaluators will be disregarded.
3.2. The Cover Page, Table of Contents, Executed Solicitation Documents (Representations and Certifications), and Pricing Sheet will not be counted toward any page limit.
3.3 The entirety of the Executive Summary, Technical Capability shall not exceed twenty (20) pages, including any appendices, matrices, and tables.
4. CONTENT OF QUOTE PARTS
File details come from the government source that posted it. Updated .